GLSI logo
GLSI
Greenwich LifeSciences

Greenwich LifeSciences will eye a valued future at $460 a share, with GP2 leading the way.

Published
09 Mar 25
Updated
18 Mar 25
White_valkyrie's Fair Value
US$460.00
97.4% undervalued intrinsic discount
18 Mar
US$12.18
Loading
1Y
-18.1%
7D
0.08%

Author's Valuation

US$460.0

97.4% undervalued intrinsic discount

White_valkyrie's Fair Value

Narrative
Updates1

Shared on10 Mar 25

White_valkyrie made no meaningful changes to valuation assumptions.

Read more